CIS
LEGN icon

Capital International Sarl’s Legend Biotech LEGN Stock Holding History

Capital International Sarl’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,758
Closed -$985K – 291
2025
Q2 		$985K Sell
27,758
-7,335
-21% -$238K 0.02% 242
2025
Q1 		$1.19M Sell
35,093
-19,240
-35% -$690K 0.03% 234
2024
Q4 		$1.77M Sell
54,333
-9,005
-14% -$373K 0.04% 196
2024
Q3 		$3.09M Sell
63,338
-30,448
-32% -$1.62M 0.08% 153
2024
Q2 		$4.15M Buy
93,786
+10,785
+13% +$498K 0.13% 136
2024
Q1 		$4.66M Hold
83,001
– – 0.15% 128
2023
Q4 		$4.99M Sell
83,001
-200
-0.2% -$12.7K 0.19% 122
2023
Q3 		$5.59M Buy
83,201
+7,072
+9% +$491K 0.26% 103
2023
Q2 		$5.26M Buy
76,129
+3,575
+5% +$234K 0.24% 113
2023
Q1 		$3.5M Sell
72,554
-1,354
-2% -$66.2K 0.18% 140
2022
Q4 		$3.69M Sell
73,908
-83,721
-53% -$4.06M 0.26% 112
2022
Q3 		$6.43M Buy
157,629
+2,129
+1% +$99.9K 0.52% 63
2022
Q2 		$8.55M Sell
155,500
-70,380
-31% -$2.97M 0.69% 39
2022
Q1 		$8.21M Sell
225,880
-18,853
-8% -$745K 0.41% 77
2021
Q4 		$11.4M Buy
244,733
+23,171
+10% +$1.18M 0.54% 48
2021
Q3 		$11.2M Buy
221,562
+1,092
+0.5% +$45.4K 0.99% 29
2021
Q2 		$9.05M Buy
220,470
+47,924
+28% +$1.63M 0.78% 40
2021
Q1 		$5.01M Sell
172,546
-121,594
-41% -$3.32M 0.48% 63
2020
Q4 		$8.28M Sell
294,140
-8,720
-3% -$251K 0.87% 36
2020
Q3 		$9.35M Sell
302,860
-12,650
-4% -$426K 1.15% 25
2020
Q2 		$13.4M Buy
+315,510
New +$12.3M 1.79% 11

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Sarl's LEGN Position: Q3 2025 in Review

Capital International Sarl sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 27,758 shares — an estimated $985K sold.

Capital International Sarl first reported a position in LEGN in Q2 2020 and held it in 21 quarters. The position peaked at $13.4M in Q2 2020. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Capital International Sarl reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Capital International Sarl sold 27,758 Legend Biotech shares in Q3 2025, an estimated $985K.
  • Capital International Sarl first reported a position in Legend Biotech in Q2 2020 and held it in 21 quarters.
  • Capital International Sarl's Legend Biotech position peaked at $13.4M in Q2 2020.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Capital International Sarl's 13F filing for Q3 2025, filed 13 Nov 2025.